Health agencies working under Robert F. Kennedy Jr. are making changes to the nation's decades-old system for approving and ...

Novavax received Food and Drug Administration approval for its new, protein-based COVID-19 vaccine, and shares jumped 25% at the opening bell Monday.

Novavax Inc. jumped in early trading after US regulators fully approved its Covid vaccine, easing investors’ concerns after ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.